+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transfection Technologies Market by Product (Instruments, Reagents & Kits), Method (Biological Transfection, Chemical Transfection, Physical Transfection), Application, End-User - Global Forecast 2025-2030- Product Image
Transfection Technologies Market by Product (Instruments, Reagents & Kits), Method (Biological Transfection, Chemical Transfection, Physical Transfection), Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Transfection Technologies Market by Product (Instruments, Reagents & Kits), Method (Biological Transfection, Chemical Transfection, Physical Transfection), Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716093
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transfection Technologies Market grew from USD 1.26 billion in 2024 to USD 1.37 billion in 2025. It is expected to continue growing at a CAGR of 8.60%, reaching USD 2.08 billion by 2030.

The transfection technologies sector is experiencing a phase of rapid evolution, underpinned by innovation and expanding applications that are reshaping how researchers and industry leaders approach gene delivery. In today’s competitive market, emerging scientific breakthroughs and technological advancements are driving heightened interest among stakeholders interested in enhancing efficiency and precision. As research intensifies and clinical applications grow in complexity, it is essential to understand the dynamics that have contributed to the foundational changes in transfection methodologies. This introduction provides an overview of the market’s current state, themes of innovation, and the substantial progress that has paved the way for a new era of therapeutic and research solutions. By examining the drivers of change and technological evolution in this rapidly growing sector, industry professionals gain critical insight into the challenges and opportunities that lie ahead.

Transformative Shifts in the Transfection Landscape

Recent years have witnessed transformative shifts that have redefined transfection technologies, revolutionizing the way gene delivery is conducted across a spectrum of applications. New approaches driven by automation and data analytics have enabled more precise modification and manipulation at the cellular level, rapidly accelerating research outputs and clinical trial progress. Pioneering techniques integrated with advanced instrumentation, the adoption of next-generation reagents, and evolutions in kit-based solutions have collectively altered the market dynamics. As innovations in both chemical and physical techniques evolve, there is a marked drive towards higher transfection efficiency and reduced cytotoxicity, which directly impacts therapeutic outcomes and experimental reliability. This period of transformation has fostered a research environment where not only the speed, but also the accuracy of gene delivery methods is paramount, setting the stage for breakthroughs in personalized medicine, gene therapies, and complex gene editing initiatives.

Comprehensive Segmentation Insights into Transfection Solutions

Within the transfection market, detailed segmentation has been critical for understanding the multifaceted nature of both product offerings and application scopes. Analyzing based on product reveals a dual focus on instruments as well as reagents and kits, each contributing distinct advantages in operational efficiency and outcome reliability. When viewed through the methodological lens, the market consideration expands across the biological, chemical, and physical transfection categories. The biological transfection spectrum is extensively organized around the use of plasmid DNA and viral vectors, signifying a robust tradition of genetic study and gene therapy intervention. In contrast, chemical transfection emphasizes methods such as calcium phosphate transfection and the increasingly popular lipofection, while physical transfection methods are notable for employing biolistic delivery through gene guns, electroporation techniques, and microinjection strategies. Extending the scope further into application-based segmentation, market analysis identifies critical focus areas including cell line development, CRISPR and gene editing innovations, gene therapy protocols, protein production strategies, and vaccination methods. Additionally, segmentation based on the end-user demographics illuminates a diverse consumer base that spans academic and research institutes, contract research organizations, hospitals and diagnostic laboratories, as well as pharmaceutical and biotechnology companies. This layered segmentation underscores the complex and expansive nature of the market, emphasizing how distinct methodologies and applications have driven tailored innovations across different facets of research and clinical practice.

Based on Product, market is studied across Instruments and Reagents & Kits.

Based on Method, market is studied across Biological Transfection, Chemical Transfection, and Physical Transfection. The Biological Transfection is further studied across Plasmid DNA and Viral Vectors. The Chemical Transfection is further studied across Calcium Phosphate Transfection and Lipofection. The Physical Transfection is further studied across Biolistic Transfection/Gene Guns, Electroporation, and Microinjection.

Based on Application, market is studied across Cell Line Development, CRISPR & Gene Editing, Gene Therapy, Protein Production, and Vaccination.

Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations (CROs), Hospitals & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.

Global Regional Insights Shaping the Transfection Market

Exploring regional insights reveals significant geographic variability in the adoption and application of transfection technologies across the global landscape. In the Americas, robust investments in research infrastructure and a high level of cross-sector collaboration continue to drive market advancements, solidifying the region’s standing as a leader in biotech innovation. Meanwhile, the Europe, Middle East & Africa region presents a dynamic interplay of well-established research institutions and emerging markets, where stringent regulatory frameworks and strong governmental support for biotechnology research are fostering a competitive environment. The Asia-Pacific zone, characterized by rapid industrial growth and increasing focus on biomedical research, is emerging as a critical hub of innovation and cost-effective solutions. The convergence of financial incentives, expanding infrastructure, and a growing base of skilled professionals in these regions is fostering a diverse set of competitive and collaborative endeavors, which are powering forward significant industry breakthroughs in transfection methodologies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insightful Analysis of Leading Transfection Companies

The transfection landscape is marked by the presence of numerous companies that are driving innovation through strategic investments in R&D and globally scaled operations. Prominent industry leaders such as Agilent Technologies, Inc., Akron Biotech LLC, and Altogen Biosystems have played instrumental roles in advancing instrumentation and workflow automation. Contributions from Bio-Rad Laboratories, Inc., Biomol GmbH, and Bioneer Corporation further underscore the significance of tailored reagent development and high-performance kit solutions. Also notable in this competitive field are organizations like Epoch Life Science, Inc. and FUJIFILM Wako Pure Chemical Corporation, which combine robust product portfolios with a consistent focus on improved delivery mechanisms. Other key players include GeneCopoeia Inc., Geno Technology, Inc., and Horizon Discovery Group plc by PerkinElmer, Inc., whose innovative approaches are redefining molecular applications across diverse clinical and research settings. The influential presence of Lonza Group and Maxcyte Inc. is paralleled by contributions from Merck KGaA, Nepa Gene Co., Ltd., and OriGene Technologies, Inc., further pushing the frontiers of gene transfer techniques. This disruptive environment is also shaped by OZ Biosciences SAS, Polyplus-transfection SA by Sartorius AG, Polysciences, Inc., as well as industry giants such as Promega Corporation, Qiagen NV, Reprocell Inc., SignaGen Laboratories LLC, Takara Bio Inc., and Thermo Fisher Scientific, Inc. Their collective innovations and market strategies form the backbone of ongoing advancements that continue to add value and foster resilience within the transfection technologies market.

The report delves into recent significant developments in the Transfection Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Akron Biotech LLC, Altogen Biosystems, Bio-Rad Laboratories, Inc., Biomol GmbH, Bioneer Corporation, Epoch Life Science, Inc., FUJIFILM Wako Pure Chemical Corporation, GeneCopoeia Inc., Geno Technology, Inc., Horizon Discovery Group plc by PerkinElmer, Inc., Lonza Group, Maxcyte Inc., Merck KGaA, Nepa Gene Co., Ltd., OriGene Technologies, Inc., OZ Biosciences SAS, Polyplus-transfection SA by Sartorius AG, Polysciences, Inc., Promega Corporation, Qiagen NV, Reprocell Inc., SignaGen Laboratories LLC, Takara Bio Inc., and Thermo Fisher Scientific, Inc..

Actionable Recommendations for Industry Leaders

Advancing transfection technologies in a competitive global market requires a proactive and strategic approach. Industry leaders are encouraged to further invest in research and development initiatives that foster collaboration between academic institutions, contract research organizations, and industrial research centers. Embracing multifaceted partnerships can help improve the integration of emerging biotechnologies, thus enhancing the effectiveness of instruments, reagents, and kit solutions. It is critical to continuously invest in automation and precision engineering to improve overall transfection performance, while also minimizing cytotoxicity and boosting throughput. Diversifying transfection methods by staying abreast of disruptive innovations in biological, chemical, and physical platforms is another strategic pillar that can bolster market positioning. Stakeholders should also work to tailor offerings to specific applications such as cell line development, advanced gene editing using CRISPR, and gene therapy protocols, ensuring that solutions are both flexible and scalable. Finally, a global mindset is essential. By capitalizing on regional opportunities and responding to local needs in areas such as the Americas, Europe, Middle East & Africa, and Asia-Pacific, companies can position themselves to capture market share and foster long-term sustainability in this evolving landscape.

Throughout this analysis, it is evident that the transfection technologies market is at a critical juncture, with transformative shifts shaping every facet of the industry. Innovative product development, robust methodological enhancements, and finely tuned segmentation strategies have collectively driven the evolution of gene delivery mechanisms and expanded the repertoire of available solutions. Regional dynamics have further diversified market approaches, with distinct opportunities identified across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In parallel, key industry players are leveraging their expertise and broad technological solutions to redefine standards and create sustainable competitive advantages. Overall, the combined momentum of R&D advancements, strategic partnerships, and targeted market strategies paints a promising picture for future developments. As the industry continues to innovate and address emerging challenges, the potential for increased efficiency and broader accessibility in transfection applications remains exceptionally high.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising awareness of RNA interference and gene editing techniques globally
5.1.1.2. Growing focus on personalized medicine and targeted gene therapies for complex disorders
5.1.1.3. Increasing global research funding in gene therapy and cellular biology applications
5.1.2. Restraints
5.1.2.1. High cost of advanced transfection reagents and lack of standardized protocols
5.1.3. Opportunities
5.1.3.1. Surging investments & funding to advance transfection technologies
5.1.3.2. Technological advancements in transfection reagent formulations to improve efficiency
5.1.4. Challenges
5.1.4.1. Stringent regulatory hurdles and safety compliance issues affecting the approval of new gene therapies
5.2. Market Segmentation Analysis
5.2.1. Product: Rising demand of reagents & kits for routine applications
5.2.2. End-User: Growing use of transfection technologies in academic & research institutes
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Transfection Technologies Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents & Kits
7. Transfection Technologies Market, by Method
7.1. Introduction
7.2. Biological Transfection
7.2.1. Plasmid DNA
7.2.2. Viral Vectors
7.3. Chemical Transfection
7.3.1. Calcium Phosphate Transfection
7.3.2. Lipofection
7.4. Physical Transfection
7.4.1. Biolistic Transfection/Gene Guns
7.4.2. Electroporation
7.4.3. Microinjection
8. Transfection Technologies Market, by Application
8.1. Introduction
8.2. Cell Line Development
8.3. CRISPR & Gene Editing
8.4. Gene Therapy
8.5. Protein Production
8.6. Vaccination
9. Transfection Technologies Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations (CROs)
9.4. Hospitals & Diagnostic Laboratories
9.5. Pharmaceutical & Biotechnology Companies
10. Americas Transfection Technologies Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Transfection Technologies Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Transfection Technologies Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. Duoning Biotechnology Group and Branca Bunús collaborate to optimize transient transfection processes for enhanced biopharmaceutical production solutions
13.3.2. STEMCELL Technologies introduces CellPore Transfection System to transform cell transfection and accelerate research in gene therapies and cancer treatments
13.3.3. Merck’s signs an agreement to acquire Mirus Bio to strengthen transfection technologies and accelerates viral vector-based gene therapy manufacturing
13.3.4. Polyplus Launches FectoVIR-LV Transfection Reagent with New DOE Service Options
13.3.5. BioCentriq and Kytopen Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing
13.3.6. Avectas Launches the Solupore Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. TRANSFECTION TECHNOLOGIES MARKET MULTI-CURRENCY
FIGURE 2. TRANSFECTION TECHNOLOGIES MARKET MULTI-LANGUAGE
FIGURE 3. TRANSFECTION TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 4. TRANSFECTION TECHNOLOGIES MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2024 VS 2030 (%)
FIGURE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TRANSFECTION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TRANSFECTION TECHNOLOGIES MARKET DYNAMICS
TABLE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CALCIUM PHOSPHATE TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY LIPOFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLISTIC TRANSFECTION/GENE GUNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CRISPR & GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 59. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 60. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 61. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 62. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 66. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 68. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 96. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 97. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 98. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 99. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 103. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 104. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 105. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 106. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 117. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 118. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 119. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 120. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 159. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 160. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 161. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 162. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 179. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 181. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 183. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 184. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 188. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 189. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 190. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 191. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 195. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 197. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 202. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 204. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 209. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 211. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 212. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 223. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 224. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 225. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 226. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 244. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 251. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 252. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 253. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 254. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 258. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 259. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 260. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 261. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 286. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 287. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 288. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 289. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 305. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 306. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 307. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 308. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 309. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 310. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOLOGICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CHEMICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TAB

Companies Mentioned

  • Agilent Technologies, Inc.
  • Akron Biotech LLC
  • Altogen Biosystems
  • Bio-Rad Laboratories, Inc.
  • Biomol GmbH
  • Bioneer Corporation
  • Epoch Life Science, Inc.
  • FUJIFILM Wako Pure Chemical Corporation
  • GeneCopoeia Inc.
  • Geno Technology, Inc.
  • Horizon Discovery Group plc by PerkinElmer, Inc.
  • Lonza Group
  • Maxcyte Inc.
  • Merck KGaA
  • Nepa Gene Co., Ltd.
  • OriGene Technologies, Inc.
  • OZ Biosciences SAS
  • Polyplus-transfection SA by Sartorius AG
  • Polysciences, Inc.
  • Promega Corporation
  • Qiagen NV
  • Reprocell Inc.
  • SignaGen Laboratories LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.08 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Transfection Reagents & Equipment Market by Product, Method, Application, End User - Global Forecast 2025-2030 - Product Image

Transfection Reagents & Equipment Market by Product, Method, Application, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report, By Product, By Method (Electroporation), By Application (Transgenic Models), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report, By Product, By Method (Electroporation), By Application (Transgenic Models), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Transfection Technologies Market Report by Product Type, Application, Transfection Method, Technology, End-User, and Region 2025-2033 - Product Image

Transfection Technologies Market Report by Product Type, Application, Transfection Method, Technology, End-User, and Region 2025-2033

  • Report
  • 147 Pages
  • Global
From
Transfection Technologies - Global Strategic Business Report - Product Image

Transfection Technologies - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Transfection Technologies Market Report 2024 - Product Image

Transfection Technologies Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Transfection Market

The Transfection market is a subset of the Genomics industry that focuses on the delivery of genetic material into cells. Transfection is a process that enables researchers to study gene function, gene expression, and gene regulation. It is used in a variety of applications, including gene therapy, drug discovery, and gene editing. Transfection reagents, such as plasmids, viral vectors, and liposomes, are used to deliver genetic material into cells. Transfection reagents are also used to study gene expression, gene regulation, and gene function. The Transfection market is highly competitive, with a number of companies offering a variety of products and services. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, Promega Corporation, Lonza Group, and Agilent Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.